Novartis settles US Securities and Exchange Commission claims of FCPA violations throughout the world
MLex Summary: Novartis AG, the Swiss drug and health care giant, paid $112.8 million to settle US Securities and Exchange Commission claims it violated books, records and internal-controls provisions of the...To view the full article, register now.
Already a subscriber? Click here to view full article